Kestra Medical Technologies, Ltd. Common Stock KMTS Income Statement
| FY'25 | ||
|---|---|---|
| $59.82M+115% | ||
| $35.61M+29.7% | ||
| $24.21M+6,588% | ||
| 40.5%+39.2pp | ||
| $15.65M+1.0% | ||
| $114.94M+64.3% | ||
| $130.59M+52.9% | ||
| $130.59M+52.9% | ||
| -$106.38M-25.1% | ||
| -177.8%+128pp | ||
| $7.73M+24.1% | ||
| $3.2M— | ||
| -$2.77M+1.3% | ||
| -$113.68M-20.8% | ||
| $135K+463% | ||
| -$113.81M-20.9% | ||
| -190.3%+148pp | ||
| $12.32M+83.3% | ||
| -$5.13-1.2% | ||
| -$5.13-1.2% | ||
| 84.2M— | ||
| 84.2M— | ||
| -$2.77M+1.3% | ||
| $59.82M+115% | ||
| -$106.38M-25.1% | ||
| -$98.41M-33.9% | ||
| -$98.41M-33.9% | ||
| -164.5%+99.7pp | ||
| -$106.38M-25.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Kestra Medical Technologies, Ltd. Common Stock's revenue?
- Kestra Medical Technologies, Ltd. Common Stock (KMTS) generated $83.7M in revenue over the trailing twelve months, up 69.0% year over year.
- Is Kestra Medical Technologies, Ltd. Common Stock profitable?
- Kestra Medical Technologies, Ltd. Common Stock is not currently profitable: it reported a net loss of $144.8M over the trailing twelve months, a -173.0% net margin.
- What are Kestra Medical Technologies, Ltd. Common Stock's profit margins?
- Gross margin is 48.8% and operating margin is -171.5%, with a -173.0% net margin.
- What is Kestra Medical Technologies, Ltd. Common Stock's earnings per share?
- Kestra Medical Technologies, Ltd. Common Stock's diluted EPS over the trailing twelve months is $-3.32.
- Where does Kestra Medical Technologies, Ltd. Common Stock's income statement data come from?
- Every line is extracted from Kestra Medical Technologies, Ltd. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
